Active Research Protocols
- 08-I-0093 – A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC
- 10-I-0197 – Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014